Increase in matrix metalloproteinase-2 level in the chicken retina after laser photocoagulation

Lasers in Surgery and Medicine

Volumn 42, Issue 5, 2010, Pages 433-441

  Takeyama, Masayuki ^a   Yoneda, Masahiko ^b   Takeuchi, Makoto ^a   Isogai, Zenzo ^c   Ohno Jinno, Akiko ^a   Kataoka, Takuya ^a   Li, Huili ^a   Sugita, Iichiro ^a   Iwaki, Masayoshi ^a   Zako, Masahiro ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b Aichi Prefectural College of Nursing and Health   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Influx; Laser photocoagulation; Matrix metalloproteinase 2; Retina; Vitreous

Indexed keywords

GELATIN; GELATINASE A; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; INTERNAL LIMITING MEMBRANE; LASER COAGULATION; MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RETINA; RETINA INJURY; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; VITREOUS BODY; ZYMOGRAPHY;

ANIMALS; CHICKENS; LASER COAGULATION; MATRIX METALLOPROTEINASE 2; RETINA;

EID: 77954415961     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20931     Document Type: Article

References (46)

1. Sivak JM, Fini ME. MMPs in the eye: Emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002;21:1-14.
2. Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 2005;85:597-607.
3. Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2003;44:2163-2170. (Pubitemid 36520313)
4. Das A, McGuire PG, Eriqat C, Ober RR, DeJuan E, Williams GA, McLamore A, Biswas J, Johnson DW. Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. Invest Ophthalmol Vis Sci 1999;40:809-813.
5. Notari L, Miller A, Martínez A, Amaral J, Ju M, Robinson G, Smith LE, Becerra SP. Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: Implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci 2005;46:2736-2747.
6. Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1998;39:2194-2200. (Pubitemid 28455093)
7. Plantner JJ, Jiang C, Smine A. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 1998;67:637-645.
8. Guo L, Hussain AA, Limb GA, Marshall J. Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroids. Invest Ophthalmol Vis Sci 1999;40:2676-2682.
9. Symeonidis C, Diza E, Papakonstantinou E, Souliou E, Dimitrakos SA, Karakiulakis G. Correlation of the extent and duration of rhegmatogenous retinal detachment with the expression of matrix metalloproteinases in the vitreous. Retina 2007;27:1279-1285. (Pubitemid 350211538)
10. Kon CH, Occleston NL, Charteris D, Daniels J, Aylward GW, Khaw PT. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1998;39:1524-1529. (Pubitemid 28307381)
11. Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Exp Eye Res 2002;74:577-584.
12. Majka S, McGuire P, Colombo S, Das A. The balance between proteinases and inhibitors in a murine model of proliferative retinopathy. Invest Ophthalmol Vis Sci 2001;42:210-215. (Pubitemid 32059432)
13. Das A, McLamore A, Song W, McGuire PG. Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. Arch Ophthalmol 1999;117:498-503. (Pubitemid 29169645)
14. El-Bradey M, Cheng L, Bartsch DU, Appelt K, Rodanant N, Bergeron-Lynn G, Freeman WR. Preventive versus treatment effect of AG3340, a potent matrix metalloproteinase inhibitor in a rat model of choroidal neovascularization. J Ocul Pharmacol Ther 2004;20:217-236.
15. Flaxel C, Bradle J, Acott T, Samples JR. Retinal pigment epithelium produces matrix metalloproteinases after laser treatment. Retina 2007;27:629-634.
16. Wilson AS, Hobbs BG, Shen WY, Speed TP, Schmidt U, Begley CG, Rakoczy PE. Argon laser photocoagulation-induced modification of gene expression in the retina. Invest Ophthalmol Vis Sci 2003;44:1426-1434.
17. Smine A, Plantner JJ. Membrane type-1 matrix metalloproteinase in human ocular tissues. Curr Eye Res 1997;16:925-929.
18. Chintala SK, Zhang X, Austin JS, Fini ME. Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem 2002;277:47461-47468.
19. Mali RS, Cheng M, Chintala SK. Intravitreous injection of a membrane depolarization agent causes retinal degeneration via matrix metalloproteinase-9. Invest Ophthalmol Vis Sci 2005;46:2125-2132.
20. Alexander SM, Jackson KJ, Bushnell KM, McGuire PG. Spatial and temporal expression of the 72-kDa type IV collagenase (MMP-2) correlates with development and differentiation of valves in the embryonic avian heart. Dev Dyn 1997;209:261-268.
21. Nishida S, Uchida H, Takeuchi M, Sui GQ, Mizutani S, Iwaki M. Scanning electron microscope study of the rabbit anterior chamber angle. Med Mol Morphol 2005;38:54-62.
22. Zweng HC, Little HL, Hammond AH. Complications of argon laser photocoagulation. Trans Am Acad Ophthalmol Otolaryngol 1974;78:OP195-OP204.
23. Meyers SM. Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy. Am J Ophthalmol 1980;90:210-216. (Pubitemid 10056125)
24. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy, ETDRS report number 9. Ophthalmology 1991;98(Suppl):766-785.
25. Fong DS, Girach A, Boney A. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: A literature review. Retina 2007;27:816-824.
26. François J, Cambie E. Further vision deterioration after argon laser photocoagulation in diabetic retinopathy. Ophthalmologica 1976;173:28-39.
27. Takahashi A, Nagaoka T, Sato E, Yoshida A. Effect of panretinal photocoagulation on choroidal circulation in the foveal region in patients with severe diabetic retinopathy. Br J Ophthalmol 2008;92:1369-1373.
28. McDonald HR, Schatz H. Macular edema following panretinal photocoagulation. Retina 1985;5:5-10. (Pubitemid 15120379)
29. Nonaka A, Kiryu J, Tsujikawa A, Yamashiro K, Nishijima K, Kamizuru H, Ieki Y, Miyamoto K, Nishiwaki H, Honda Y, Ogura Y. Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina. Invest Ophthalmol Vis Sci 2002;43:1204-1209.
30. Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 2005;115:599-609.
31. Yamaguchi M, Jadhav V, Obenaus A, Colohan A, Zhang JH. Matrix metalloproteinase inhibition attenuates brain edema in an in vivo model of surgically induced brain injury. Neurosurgery 2007;61:1067-1075. (Pubitemid 350306967)
32. Vilalta A, Sahuquillo J, Rosell A, Poca MA, Riveiro M, Montaner J. Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases. Intensive Care Med 2008;34:1384-1392.
33. Rosenberg GA. Matrix metalloproteinases in brain injury. J Neurotrauma 1995;12:833-842.
34. Stefánsson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 2009;247:147-163.
35. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
36. Brown DJ, Bishop P, Hamdi H, Kenney MC. Cleavage of structural components of mammalian vitreous by endogenous matrix metalloproteinase-2. Curr Eye Res 1996;15:439-445. (Pubitemid 26140482)
37. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts, Purification and activation of the precursor and enzymic properties. Eur J Biochem 1990;194:721-730.
38. Masuyama Y, Kodama Y, Matsuura Y, Kodama Y, Hagihara S, Sawada A. Effects of panretinal photocoagulation on vitreoretinal border tissues: IV. Freeze-cracking SEM of macaca fuscata. Nippon Ganka Gakkai Zasshi 1988;92:1213-1220.
39. Katoh N, Peyman GA. Dye orange and argon green laser photocoagulation effects on the retina and vitreoretinal interface. Jpn J Ophthalmol 1987;31:461-466. (Pubitemid 17141475)
40. Adithi M, Nalini V, Kandalam M, Krishnakumar S. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma. J Pediatr Hematol Oncol 2007;29:399-405.
41. Sánchez MC, Barcelona PF, Luna JD, Ortiz SG, Juarez PC, Riera CM, Chiabrando GA. Low-density lipoprotein receptor-related protein-1 (LRP-1) expression in a rat model of oxygen-induced retinal neovascularization. Exp Eye Res 2006;83:1378-1385.
42. Hoffmann S, He S, Ehren M, Ryan SJ, Wiedemann P, Hinton DR. MMP-2 and MMP-9 secretion by rpe is stimulated by angiogenic molecules found in choroidal neovascular membranes. Retina 2006;26:454-461.
43. Ahuja S, Ahuja P, Caffé AR, Ekstrom P, Abrahamson M, van Veen T. Rd1 mouse retina shows imbalance in cellular distribution and levels of TIMP-1/MMP-9, TIMP-2/MMP-2 and sulfated glycosaminoglycans. Ophthalmic Res 2006;38:125-136.
44. González-Avila G, Méndez D, Lozano D, Ramos C, Delgado J, Iturria C. Role of retinal detachment subretinal fluid on extracellular matrix metabolism. Ophthalmologica 2004;218:49-56.
45. Paulus YM, Jain A, Gariano RF, Stanzel BV, Marmor M, Blumenkranz MS, Palanker D. Healing of retinal photocoagulation lesions. Invest Ophthalmol Vis Sci 2008;49:5540-5545.
46. Belokopytov M, Belkin M, Dubinsky G, Epstein Y, Rosner M. Development and recovery of laser-induced retinal lesion in rats. Retina 2010;30:662-670.